• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    More On TIS.AX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Tissue Therapies Ltd. (TIS.AX)

    0.28 0.00(0.00%) Dec 23
    Add to Portfolio
    ProfileGet Profile for:
    Tissue Therapies Ltd.
    179 Turbot Street
    Level 19
    Brisbane, QLD 4000
    Australia - Map
    Phone: 61 7 3334 3900
    Fax: 61 7 3334 3999
    Website: http://www.tissuetherapies.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Tissue Therapies Limited, a biomedical technology company, researches, develops, and commercializes biomedical technologies for chronic wound healing and tissue regeneration worldwide. The company commercializes VitroGro ECM, a biomimetic scaffold comprising a synthetic extracellular matrix protein that replaces the degraded matrix of a hard to heal wounds for the patients and the healthcare providers. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns, as well as treatments for psoriasis, scar prevention, and various cancers, such as breast, colon, and prostate. Tissue Therapies Limited is headquartered in Brisbane, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Tissue Therapies Ltd.

    Key Executives 
    Dr. Steven John Mercer ,
    Chief Exec. Officer, Managing Director and Exec. Director
    Mr. Drummond McKenzie ,
    Chief Financial Officer and Company Sec.
    Mr. Nigel Johnson ,
    Operations Director
    Ms. Saskia Jo ,
    Corp. Accountant
    Dr. Zee Upton Ph.D.,
    Consulting Chief Scientific Officer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.